Maridea Wealth Management LLC Makes New $222,000 Investment in UnitedHealth Group Incorporated $UNH

Maridea Wealth Management LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 712 shares of the healthcare conglomerate’s stock, valued at approximately $222,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the period. Wellington Management Group LLP lifted its stake in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. GAMMA Investing LLC increased its position in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares during the period. Bank of New York Mellon Corp lifted its position in shares of UnitedHealth Group by 2.5% in the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after purchasing an additional 196,696 shares during the period. Finally, Nuveen LLC acquired a new stake in shares of UnitedHealth Group during the first quarter worth $3,846,764,000. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UNH stock opened at $345.84 on Friday. The company has a market capitalization of $313.22 billion, a P/E ratio of 14.98, a price-to-earnings-growth ratio of 2.29 and a beta of 0.45. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The business has a 50-day simple moving average of $299.96 and a two-hundred day simple moving average of $361.40. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. During the same period in the previous year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s payout ratio is 38.30%.

Analyst Upgrades and Downgrades

UNH has been the subject of several research analyst reports. Sanford C. Bernstein lifted their price objective on UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Bank of America lifted their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Monday, August 18th. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $358.95.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.